drugset
drugset / Trial / NCT01511887

Safety and Efficacy of Ibuprofen in Term Newborns With Patent Ductus Arteriosus (PDA)

NCT01511887 ↗

Completed 40 enrolled Hormozgan University of Medical Sciences
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of current study is to evaluate the efficacy and safety of oral Ibuprofen in term 20-28 days old newborn referred to Bandarabbas children' hospital in 2011.

Timeline

Start
2011-01
Primary completion
2011-12
Completion
2012-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Ibuprofen Small molecule 5 mg/kg Oral

Indications

patent ductus arteriosus